home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Biobanking Congress

 
  March 27, 2018  
     
 
Oxford Global, Novotel London West, Hammersmith, London
25th-26th October 2018


Across two days, over 150 leading biobanking, biomarker and sample management experts will come together to discuss the most recent developments within the industry.  The Biobanking congress will bring together key speakers from Europe’s leading biorepositories and biobanks to explore key insights into biosample management, standards, quality management as well as future advances in areas such as regulations and collaboration. Pertinent to the importance of Biobanking in discovery and clinical development, we look at the role it plays in biomarker and translational development. The presentations by leading pharmaceutical companies will feature biobanking and case studies in biomarker-driven clinical trials and the role that biobanking plays in driving precision medicine.

Include 2 interactive streams:

  • Day 1: Biobanking Regulation, Biospecimen, Standards and Novel Methods in Sample Management
  • Day 2: Biobanking in Biomarkers, Clinical Trials and Precision Medicine

View Agenda: http://bit.ly/2Crbt7g
 
 
Organized by: Oxford Global
Invited Speakers:

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

2018 Biobanking Congress Speakers include:

Jarema Kochan, Director Clinical Biomarker
Daiichi Sankyo

Arthur Lewis, Associate Director
MedImmune

Maria Hernandez-Fuentes, Head of Translation Biology for Immunology
UCB

Gerben Bouma, GlaxoSmithKline Fellow, Head of Translational Medicine, Cytokine, Chemokine and Complement DPU, Immunoinflammation TAU
GlaxoSmithKline

Grégoire Zorza, Head of Clinical Biology, Translational Medicine
Pierre Fabre Laboratories

Elodie Nasica, Head of Compound Management & Biobanking Department
Servier

Mario Richter, Principal Scientist
AbbVie

Anne Bahr, Research & Development Privacy Officer
Sanofi

Jessica Neisen, Investigator
GlaxoSmithKline

Marco Schmidt, C0-Chief Executive Officer & Chief Scientific Officer
Biotx.ai GmbH

Erik Steinfelder, Director General
BBMRI-ERIC

Laurent Dollé, Managing Director
University Libre of Brussels 

Peadar MacGabhann, Director
Biostor Ireland

Zhaxybay Zhumadilov, General Director
National Laboratory Astana

Balwir Matharoo-Ball, Deputy Director
Nottingham Health Science Biobank (NHSB)

Vasiliki Kalodimou, Lab Director, Flow Cytometry-Research & Regenerative Medicine
IASO Maternity Hospital

Aida Santaolalla, Clinical Database Manager & Prostate Cancer Biobank Coordinator
King’s College London

Michael Hisbergues, Consortium Manager – Biobanks
Inserm

Emma Snapes, Biobank and Laboratory Manager
University College Cork, Infant

 

 
Deadline for Abstracts: 23rd October
 
Registration:

To Register Click here

Alternatively for more information contact g.alonso@oxfordglobal.co.uk or join the congress conversation on Twitter @biobanking_conf or our Biobanking Networking LinkedIn Group

 

 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.